The accuracy of interqual criteria in determining the need for observation versus hospitalization in emergency department patients with chronic heart failure

Critical Pathways in Cardiology

Volumn 12, Issue 4, 2013, Pages 192-196

  Wang, Hao ^a   Robinson, Richard D ^a   Coppola, Marco ^a   Fernandez, David ^a   Ros, Ferran ^a   Zenarosa, Nestor R ^a   Burton, Mandy J ^a   Delaney, Kathleen A ^a  

^a JPS Health Network   (United States)

Author keywords

Chronic heart failure; Hospitalization; Interqual criteria; Length of stay; Observation

Indexed keywords

NITROGEN; UREA;

ADULT; ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; CRITERION VARIABLE; EMERGENCY WARD; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; INTERQUAL CRITERION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; MIDDLE AGED; PREDICTIVE VALUE; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; DIAGNOSTIC TESTS, ROUTINE; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART FAILURE; HEART FUNCTION TESTS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; WATCHFUL WAITING;

EID: 84892165950     PISSN: 1535282X     EISSN: 15352811     Source Type: Journal    
DOI: 10.1097/HPC.0b013e3182a313e1     Document Type: Article

References (20)

1. McKendry MJ, Van Horn J. Today's hospital-based case manager: how one hospital integrated/adopted evidenced-based medicine using InterQual criteria. Lippincotts Case Manag. 2004;9:61-71.
2. Jacobs CM. Managing demand using clinical decision support tools. Healthc Financ Manage. 1997;51:41-42.
3. Mitus AJ. The birth of InterQual: evidence-based decision support criteria that helped change healthcare. Prof Case Manag. 2008;13:228-233.
4. He J, Ogden LG, Bazzano LA, et al. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med. 2001;161:996-1002.
5. Poulos CJ, Eagar K, Poulos RG. Managing the interface between acute care and rehabilitation -can utilisation review assist? Aust Health Rev. 2007;31(Suppl 1):S129-S140.
6. Bruce S, DeCoster C, Trumble-Waddell J, et al. Patients hospitalized for medical conditions in Winnipeg, Canada: appropriateness and level of care. Healthc Manage Forum. 2002;Suppl:53-57.
7. I rvin CB, Nigl J, Lowe RA. Accuracy of interqual criteria in determining the hospitalization need in medicare patients with gastrointestinal bleeding. Acad Emerg Med. 2000;7:552-553.
8. G oldman RL, Weir CR, Turner CW, et al. Validity of utilization management criteria for psychiatry. Am J Psychiatry. 1997;154:349-354.
9. Smith CB, Goldman RL, Martin DC, et al. Overutilization of acute-care beds in Veterans Affairs hospitals. Med Care. 1996;34:85-96.
10. G lassman PA, Lopes JH, Witt T. Using proprietary methods to evaluate acute care admissions to a Veterans Affairs tertiary care center: are the appropriateness criteria appropriate? Am J Med Qual. 1997;12:165-168.
11. DeCoster C, Roos NP, Carrière KC, et al. Inappropriate hospital use by patients receiving care for medical conditions: targeting utilization review. CMAJ. 1997;157:889-896.
12. Klein L, Massie BM, Leimberger JD, et al.; OPTIME-CHF Investigators. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circ Heart Fail. 2008;1:25-33.
13. Filippatos G, Rossi J, Lloyd-Jones DM, et al. Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTI V in CHF) study. J Card Fail. 2007;13:360-364.
14. G raff L, Orledge J, Radford MJ, et al. Correlation of the Agency for Health Care Policy and Research congestive heart failure admission guideline with mortality: peer review organization voluntary hospital association initiative to decrease events (PROVIDE) for congestive heart failure. Ann Emerg Med. 1999;34(4, Part 1):429-437.
15. Pocock SJ, Wang D, Pfeffer MA, et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J. 2006;27:65-75.
16. A dams KF Jr., Fonarow GC, Emerman CL, et al.; ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209-216.
17. McMurray J, Ostergren J, Pfeffer M, et al; CHARM committees and investigators. Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur J Heart Fail. 2003;5:261-270.
18. Stoltzfus S. The role of noninvasive ventilation: CPAP and BiPAP in the treatment of congestive heart failure. Dimens Crit Care Nurs. 2006;25:66-70.
19. E ichhorn EJ, Lukas MA, Wu B, et al. Effect of concomitant digoxin and carvedilol therapy on mortality and morbidity in patients with chronic heart failure. Am J Cardiol. 2000;86:1032-1035, A10-1.
20. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709-717.